Xeris Pharmaceuticals | XERS - Trade Creditors

Stock Price
6.24
Daily Change
-0.14 -2.19%
Monthly
1.96%
Yearly
27.87%
Q2 Forecast
6.11

Xeris Pharmaceuticals reported $11.47M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Celltrion KRW 78.68B 25.51B Dec/2025
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Eli Lilly USD 5.03B 350M Mar/2026
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Ovoca Bio EUR 186K 23K Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pharma Mar EUR 43.83M 10.51M Mar/2026
Qiagen NV USD 72.66M 2.11M Dec/2025
Sartorius EUR 345.3M 2.2M Mar/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025
Zealand Pharma A/S 346.6M 102.71M Dec/2025
Zz Pientze Pharmaceu CNY 457.05M 59.09M Mar/2026